dusigitumab human monoclon antibodi design treatment cancer bind igf develop medimmun acquir astrazeneca use xenomous technolog licens abgenix develop discontinu mexi melanoma ecromeximab monoclon antibodyrel articl stub help wikipedia expand antineoplast immunomodulatori drug articl stub help wikipedia expand